Improved Glycemic Control and Weight Loss with Once-Weekly Dulaglutide vs. Placebo, Both Added to Titrated Daily Insulin Glargine, in Type 2 Diabetes Patients (AWARD-9). Abstract (American Diabetes Association 2016, Abstract No. 237-OR) - Pozzilli, P; Norwood, P; Esteban, J
Letzter Zugriff: 12. August 2016